Dieldrin-induced differential gene methylation and parkinsonian toxicity (R01ES031237)
狄氏剂诱导的差异基因甲基化和帕金森毒性 (R01ES031237)
基本信息
- 批准号:10709194
- 负责人:
- 金额:$ 36.03万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-11-10 至 2025-10-31
- 项目状态:未结题
- 来源:
- 关键词:3-DimensionalAdultAffectBiologicalBiological AssayBrainCandidate Disease GeneCell Culture TechniquesCorpus striatum structureDNA Modification ProcessDNMT3aDataDevelopmentDieldrinDiseaseDisease susceptibilityDopamineElderlyEnvironmentEnvironmental Risk FactorEpidemiologyEpigenetic ProcessEtiologyExposure toFunctional disorderFundingGene ExpressionGene Expression ProfileGenesGeneticGoalsHDAC9 geneHigh Pressure Liquid ChromatographyImmunohistochemistryIn SituIn VitroIndividualInheritedInjectionsKnowledgeLinkLuciferasesMass Spectrum AnalysisMediatingMediatorMethodsMethylationMissionModelingModificationMusMutationNR4A2 geneNational Institute of Environmental Health SciencesNeuritesNeuronsParkinson DiseaseParkinsonian DisordersPathogenesisPathologicPathway AnalysisPathway interactionsPeriodicityPersonsPhenotypePlayPredispositionPresynaptic TerminalsRadioactiveRiskRisk FactorsRoleScanningSequencing By HybridizationsSite-Directed MutagenesisSpecificitySystemTestingToxic Environmental SubstancesToxic effectWestern Blottingalpha synucleincandidate identificationcell typecytotoxicitydopaminergic neuronepidemiology studyepigenomeexperimental studygenome-widegenomic locusin vivoin vivo Modellaser capture microdissectionmalemethylation patternmotor behaviormouse modelneurotransmissionnigrostriatal pathwaynoveloffspringorganochlorine pesticidepesticide exposurepre-formed fibrilresponsesexsporadic Parkinson&aposs Diseasesynaptic functionsynucleinopathytooltoxicanttranscriptome sequencinguptake
项目摘要
Project Summary
The majority of Parkinson’s disease (PD) cases are not caused by an inherited monogenic mutation and
disease etiology involves a combination of genetic and environmental factors. Epidemiological studies show
that pesticide exposure, particularly to organochlorine pesticides such as dieldrin, increases risk of sporadic
PD. In a model of increased PD susceptibility, mice exposed to dieldrin during development show male-specific
increased susceptibility to adult exposure to the dopaminergic toxicant MPTP and, in new data from our
NIEHS-funded R21, α-synuclein (α-syn) preformed fibrils (PFFs). The epigenome is a potential mediator of this
relationship between developmental exposures, increased neuronal vulnerability, and adult disease. In line
with this idea, we recently identified sex-specific differential methylation patterns in response to developmental
dieldrin exposure. We hypothesize that dieldrin-induced epigenetic modifications during development
cause changes in gene expression and phenotype that persist into adulthood, altering the sensitivity
to parkinsonian insults and contributing to the development of PD.
To test this hypothesis, we will determine cell-type specific DNA modifications and expression profiles of
previously identified candidate genes in the dieldrin model (Aim 1); analyze the function of synaptic terminals in
our novel dieldrin/PFF two-hit model (Aim 2); and determine if dieldrin or altered expression of candidate genes
affects susceptibility to α-syn PFFs in a dopaminergic neuron cell culture model (Aim 3). The long-term goal
of these experiments is to determine whether dieldrin-associated differentially methylated genes play a
functional role in the biological response to parkinsonian toxicity.
Completion of these aims will further the mission of NIEHS to increase our understanding of how the environment
affects people in order to promote healthier lives, with a specific project goal of connecting exposures with
functional changes in gene expression, neuronal phenotype, and PD susceptibility. The experiments proposed
here will help to establish a biological mechanism linking developmental exposure to late life disease. This project
will also expand our repertoire of tools for interrogating the function of epigenetic changes by establishing an in
vitro experimental paradigm to connect specific epigenetic mechanisms with parkinsonian toxicity. With our in
vivo model that combines developmental exposure with adult PFF injections, we will have a set of experimental
systems in place that will allow us to test a wide variety of exposures, as well as combinations of exposures,
both in vivo and in vitro. Together, this suite of tools will enable us to explore the mechanisms by which PD-
related exposures alter neuronal vulnerability in PD, furthering the goal of NIEHS to understand how combined
exposures affect disease pathogenesis and individual susceptibility.
项目概要
大多数帕金森病 (PD) 病例并非由遗传性单基因突变引起,
流行病学研究表明,疾病病因涉及遗传和环境因素。
接触杀虫剂,尤其是狄氏剂等有机氯杀虫剂,会增加散发性感染的风险
在PD易感性增加的模型中,在发育过程中接触狄氏剂的小鼠表现出雄性特异性。
成人接触多巴胺能毒物 MPTP 的易感性增加,并且根据我们的新数据
NIEHS 资助的 R21,α-突触核蛋白(α-syn)预形成原纤维(PFF)是这种现象的潜在调节者。
发育暴露、神经脆弱性增加和成人疾病之间的关系。
有了这个想法,我们最近确定了响应发育的性别特异性差异甲基化模式
我们勇敢地面对狄氏剂在发育过程中引起的表观遗传修饰。
导致基因表达和表型的变化持续到成年,改变敏感性
帕金森病的侮辱并促进帕金森病的发展。
为了验证这一假设,我们将确定细胞类型特异性 DNA 修饰和表达谱
先前在狄氏剂模型中确定的候选基因(目标 1);分析突触末端的功能;
我们的新型狄氏剂/PFF 两次打击模型(目标 2)并确定狄氏剂或候选基因的表达是否发生改变;
影响多巴胺能神经元细胞培养模型中对 α-syn PFF 的敏感性(目标 3)。
这些实验的目的是确定狄氏剂相关的差异甲基化基因是否发挥作用
在帕金森毒性的生物反应中的功能作用。
完成这些目标将进一步履行 NIEHS 的使命,即增加我们对环境如何影响的了解。
影响人们以促进更健康的生活,具体项目目标是将暴露与
实验提出了基因表达、神经表型和 PD 易感性的功能变化。
该项目将有助于建立一种将发育暴露与晚年疾病联系起来的生物机制。
还将通过建立一个内部模型来扩展我们用于询问表观遗传变化功能的工具库。
将特定表观遗传机制与帕金森毒性联系起来的体外实验范例。
将发育暴露与成人 PFF 注射相结合的体内模型,我们将有一组实验
适当的系统将使我们能够测试各种暴露以及暴露的组合,
这套工具将使我们能够在体内和体外探索 PD-的机制。
相关暴露改变了 PD 中的神经元脆弱性,进一步推进了 NIEHS 的目标,即了解如何结合
暴露影响疾病发病机制和个体易感性。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Alison Bernstein其他文献
Alison Bernstein的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Alison Bernstein', 18)}}的其他基金
Diversity Supplement to Dieldrin-induced differential gene methylation and parkinsonian toxicity (R01ES031237)
狄氏剂诱导的差异基因甲基化和帕金森毒性的多样性补充 (R01ES031237)
- 批准号:
10847611 - 财政年份:2023
- 资助金额:
$ 36.03万 - 项目类别:
Identification of epigenetic marks underlying exercise-induced neuroprotection in Parkinson’s disease
帕金森病运动诱导神经保护的表观遗传标记的鉴定
- 批准号:
10528178 - 财政年份:2022
- 资助金额:
$ 36.03万 - 项目类别:
Dieldrin-induced differential gene methylation and parkinsonian toxicity
狄氏剂诱导的差异基因甲基化和帕金森毒性
- 批准号:
10331048 - 财政年份:2021
- 资助金额:
$ 36.03万 - 项目类别:
Dieldrin-induced differential gene methylation and parkinsonian toxicity
狄氏剂诱导的差异基因甲基化和帕金森毒性
- 批准号:
10115257 - 财政年份:2021
- 资助金额:
$ 36.03万 - 项目类别:
Epigenetic effects of adult and developmental exposure to Parkinsonian toxicants
成人和发育期接触帕金森毒物的表观遗传效应
- 批准号:
9391761 - 财政年份:2017
- 资助金额:
$ 36.03万 - 项目类别:
Epigenetic effects of adult and developmental exposure to parkinsonian toxicants
成人和发育期接触帕金森毒物的表观遗传效应
- 批准号:
8767225 - 财政年份:2014
- 资助金额:
$ 36.03万 - 项目类别:
相似国自然基金
成人免疫性血小板减少症(ITP)中血小板因子4(PF4)通过调节CD4+T淋巴细胞糖酵解水平影响Th17/Treg平衡的病理机制研究
- 批准号:82370133
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
依恋相关情景模拟对成人依恋安全感的影响及机制
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
生活方式及遗传背景对成人不同生命阶段寿命及死亡的影响及机制的队列研究
- 批准号:
- 批准年份:2021
- 资助金额:56 万元
- 项目类别:面上项目
成人与儿童结核病发展的综合研究:细菌菌株和周围微生物组的影响
- 批准号:81961138012
- 批准年份:2019
- 资助金额:100 万元
- 项目类别:国际(地区)合作与交流项目
统计学习影响成人汉语二语学习的认知神经机制
- 批准号:31900778
- 批准年份:2019
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
相似海外基金
A HUMAN IPSC-BASED ORGANOID PLATFORM FOR STUDYING MATERNAL HYPERGLYCEMIA-INDUCED CONGENITAL HEART DEFECTS
基于人体 IPSC 的类器官平台,用于研究母亲高血糖引起的先天性心脏缺陷
- 批准号:
10752276 - 财政年份:2024
- 资助金额:
$ 36.03万 - 项目类别:
Endothelial Cell Reprogramming in Familial Intracranial Aneurysm
家族性颅内动脉瘤的内皮细胞重编程
- 批准号:
10595404 - 财政年份:2023
- 资助金额:
$ 36.03万 - 项目类别:
Targeting Menin in Acute Leukemia with Upregulated HOX Genes
通过上调 HOX 基因靶向急性白血病中的 Menin
- 批准号:
10655162 - 财政年份:2023
- 资助金额:
$ 36.03万 - 项目类别:
3D Methodology for Interpreting Disease-Associated Genomic Variation in RAG2
解释 RAG2 中疾病相关基因组变异的 3D 方法
- 批准号:
10724152 - 财政年份:2023
- 资助金额:
$ 36.03万 - 项目类别: